Skip to main content

How Merck, a vaccine titan, lost the COVID race

By The New York Times  
   February 12, 2021

After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.

Full story


Get the latest on healthcare leadership in your inbox.